13 Jun 2025
🏥FDA Pediatric Advisory Committee Meeting Notice for Public Comments
Pediatric Advisory Committee (PAC); Notice of Meeting; Establishment of a Public Docket; Request for Comments
Summary
The Food and Drug Administration (FDA or the Agency) announces a forthcoming public advisory committee meeting of the Pediatric Advisory Committee (PAC). The general function of the committee is to provide advice and recommendations to FDA on pediatric regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
Agencies
- Health and Human Services Department
- Food and Drug Administration
Business Impact
$$ - Med
The notice outlines a public meeting by the FDA to discuss pediatric regulatory issues and encourages businesses to submit comments regarding specific pediatric-focused medical products. This interaction may influence product regulation and market access, impacting businesses in the healthcare and pharmaceutical sectors.